Biomarker: F201-IgE Pecan Nut

Overview

F201-IgE Pecan Nut measures serum immunoglobulin E (IgE) antibodies specific to pecan-nut allergens. IgE is involved in immediate hypersensitivity reactions, including symptoms such as hives, gastrointestinal symptoms, respiratory symptoms, and anaphylaxis. A higher result indicates sensitization to pecan proteins, but it does not by itself confirm clinical allergy or predict reaction severity. The test is clinically useful when interpreted with the patient’s reaction history, examination, and, when necessary, supervised oral food challenge testing.

Clinical Use Cases

Supports evaluation of suspected IgE-mediated pecan allergy.
Helps identify pecan as a possible trigger in patients with immediate symptoms after eating pecan or foods containing pecan.
Assists assessment of possible co-allergy between pecan and walnut, which are closely associated tree-nut allergens.
Provides evidence of sensitization when skin-prick testing is unsuitable, unavailable, or affected by skin disease.
Helps guide decisions about dietary avoidance and whether further evaluation, including an oral food challenge, is appropriate.
May be used in clinical research involving tree-nut sensitization and allergy.

Specimen Types

Serum, obtained from venous blood, is the standard specimen for allergen-specific IgE measurement.
Plasma may be accepted by some assay systems, subject to the testing laboratory’s validated requirements.

Measurement Methods

Automated fluorescent enzyme immunoassay or other solid-phase immunoassays for allergen-specific IgE.
Enzyme-linked immunosorbent assay (ELISA).
Chemiluminescent immunoassay.
Radioallergosorbent testing, an older method that has largely been replaced by newer immunoassays.
Results are commonly reported in kUA/L or an equivalent standardized concentration unit. Assay-specific reference categories may differ.
Component-resolved testing may measure IgE to individual pecan proteins, such as Car i 1, when available, but F201 generally refers to testing against a pecan-nut extract rather than a single component.

Test Preparation and Influencing Factors

Fasting is generally not required for a serum-specific IgE blood test.
Patients should provide a complete list of prescription medicines, over-the-counter medicines, vitamins, and supplements.
Antihistamines can interfere with skin-prick testing but generally do not prevent serum-specific IgE measurement. Medication changes should be made only according to a healthcare professional’s instructions.
Recent exposure to pecan does not establish or exclude allergy and should not be deliberately induced before testing.
Results may be affected by the clinical context, including age, atopic disease, total IgE concentration, and sensitization to related tree nuts.
A positive result indicates sensitization, not necessarily symptomatic allergy. A negative or low result also requires interpretation in relation to the clinical history.
The concentration of pecan-specific IgE does not reliably predict the severity of a future allergic reaction.
Large, nonspecific food panels can produce clinically irrelevant positive results; testing should generally be directed by a relevant history.